- Why fasting lowers IGF-1 and insulin — and why that matters for dormant cancer cells
- How autophagy (cellular self-cleaning) is activated by fasting and why it removes pre-cancerous material
- Three clinically distinct protocols: IF 16:8, Fasting-Mimicking Diet (FMD), and perioperative fasting
- Who should NOT fast — important contraindications for cancer survivors
Fasting is not starvation. It is a strategic pattern of eating that exploits a fundamental difference between healthy cells and cancer cells: healthy cells adapt to scarcity; cancer cells cannot.
This chapter presents fasting protocols supported by clinical research — particularly the work of Prof. Valter Longo (USC Longevity Institute), whose human fasting trials produced some of the most striking data in integrative oncology.
The Biology of Fasting and Cancer Cells
Differential Stress Resistance (DSR) is the key concept discovered by Prof. Longo. When you fast, your healthy cells enter a self-protective mode — they slow growth, reduce energy consumption, and become more resistant to stress. Cancer cells, having lost normal regulatory mechanisms, cannot make this adaptation. They remain exposed while healthy cells shelter.
Think of it as: healthy cells go into an underground bunker during a storm. Cancer cells remain standing in the open field.
| Biological Effect | How Fasting Produces It | Anti-Cancer Relevance |
|---|---|---|
| IGF-1 Reduction | Insulin-like Growth Factor 1 drops 30–40% after 24–72 hour fast | IGF-1 directly signals cancer cell proliferation — lower levels = less growth stimulus for dormant cells |
| Insulin Reduction | Insulin levels normalize and drop in 12–16 hours of fasting | Cancer cells preferentially use glucose (Warburg effect) — lower insulin = less glucose supply signaling |
| Autophagy Activation | Begins at 12–16 hours; peaks at 24–48 hours | Cells digest their own damaged components — removes pre-cancerous cellular debris before it can mutate further |
| Ketone Body Production | At 18–24 hours, liver converts fat to ketones as alternate fuel | Cancer cells poorly metabolize ketones (they prefer glucose); healthy cells adapt efficiently |
| Immune Regeneration | Prolonged fasting (>3 days) triggers hematopoietic stem cell activation | New immune cells generated — particularly relevant for survivors with chemo-depleted immune reserves |
Protocol 1: Intermittent Fasting 16:8 (Maintenance Phase)
Best for: survivors in the recovery and recurrence prevention phase. Appropriate as an ongoing daily practice.
Protocol 2: Fasting-Mimicking Diet (FMD) — Monthly Reset
Developed by Prof. Valter Longo; clinical trial Phase II data exists for cancer populations. Best for: active recovery phase, post-treatment survivors.
FMD is not complete fasting — it is a 5-day very low calorie protocol that simulates the biological state of fasting while providing minimal essential nutrition. Conducted once per month (or once per quarter, depending on tolerance and medical guidance).
| Day | Total Calories | Macronutrient Composition |
|---|---|---|
| Day 1 | ±1,100 kcal | 11% protein, 46% healthy fat, 43% complex carbohydrate |
| Days 2–5 | ±700 kcal | 9% protein, 44% healthy fat, 47% complex carbohydrate |
- Vegetable soup without meat or poultry (pumpkin, carrot, broccoli, spinach)
- A small handful of almonds or walnuts (healthy fat source)
- 1–2 dates (natural carbohydrate)
- Herbal teas without sugar (ginger, chamomile, turmeric)
- Unsalted vegetable broth
Documented FMD effects: Average IGF-1 reduction 24% after 5 days; fasting glucose drops 9–11 mg/dL; ketone body production increases; immune stem cell regeneration stimulated (Longo clinical trials, 2015–2020).
Protocol 3: Perioperative Fasting (Around Chemotherapy)
Only with explicit oncologist approval. Based on USC and European Cancer Centre research.
| Timing | Approach | Goal |
|---|---|---|
| 24–48 hours before chemo | Reduce intake to ±25% normal (vegetable soups, herbal teas, water) | Shift healthy cells into DSR protective mode before toxic drug arrives |
| Day of chemo | Water and clear vegetable broth only | Maximum healthy cell protection; maximum cancer cell exposure |
| 24 hours post-chemo | Continue clear liquids; introduce soft foods gradually | Allow post-treatment acute recovery; minimize digestive burden |
| 48+ hours post-chemo | Return to normal anti-inflammatory eating pattern | Rebuild nutritional status for next cycle |
Protocol Comparison
| Protocol | Duration | Difficulty | Best For | Primary Benefit |
|---|---|---|---|---|
| IF 16:8 | Daily | ★☆☆ | Maintenance & prevention | IGF-1 ↓, autophagy (mild), blood sugar stability |
| FMD 5-day | 5 days/month | ★★☆ | Active recovery phase | IGF-1 ↓↓, immune regeneration, ketosis |
| Perioperative | Around chemo | ★★★ | During treatment (doctor-approved only) | Protect healthy cells, sensitize cancer cells to chemo |
- Differential Stress Resistance is the biological mechanism that makes fasting selectively harmful to cancer cells while protective for healthy cells — healthy cells adapt, cancer cells cannot.
- IGF-1 reduction of 30–40% is achievable with 24–72 hour fasting — this directly removes one of cancer's key proliferation signals.
- Autophagy begins at 12–16 hours and peaks at 24–48 hours — it physically removes damaged cellular components that could otherwise progress to malignancy.
- IF 16:8 is the most accessible entry point: sustainable, daily, and produces meaningful metabolic improvements with minimal disruption.
- Always discuss any fasting protocol with your oncologist before implementation — this is especially important if you have had recent weight loss or are at risk for malnutrition.